GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 46 filers reported holding GEMINI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $562,000 | -56.4% | 342,532 | -55.1% | 0.00% | -100.0% |
Q2 2022 | $1,288,000 | +72.9% | 762,163 | +42.1% | 0.00% | – |
Q1 2022 | $745,000 | -49.5% | 536,202 | +5.7% | 0.00% | -100.0% |
Q4 2021 | $1,476,000 | -47.4% | 507,328 | -27.0% | 0.00% | 0.0% |
Q3 2021 | $2,807,000 | +69.6% | 694,707 | +171.6% | 0.00% | 0.0% |
Q2 2021 | $1,655,000 | -63.0% | 255,742 | -22.5% | 0.00% | -66.7% |
Q1 2021 | $4,472,000 | – | 330,019 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management V, LLC | 2,435,125 | $15,755,000 | 6.20% |
Orbimed Advisors | 5,826,224 | $37,696,000 | 0.38% |
Boxer Capital, LLC | 1,300,000 | $8,411,000 | 0.30% |
Ikarian Capital, LLC | 426,455 | $2,759,000 | 0.22% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,135,000 | $13,813,000 | 0.21% |
JS Capital Management LLC | 474,457 | $3,070,000 | 0.15% |
HARVARD MANAGEMENT CO INC | 250,000 | $1,618,000 | 0.09% |
Alyeska Investment Group, L.P. | 837,584 | $5,419,000 | 0.06% |
Virtus ETF Advisers LLC | 19,673 | $127,000 | 0.05% |
Caption Management, LLC | 384,900 | $2,488,000 | 0.03% |